A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer
Condition: Epithelial Ovarian Cancer Intervention: Drug: Envafolimab Sponsor: Hebei Medical University Fourth Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Epithelial Cancer | Fallopian Tube Cancer | Hospitals | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research | Study